1. Ohno, Kinji, Ohkawara, Bisei, Shen, Xin-Ming, Selcen, Duygu, Engel, Andrew G. 2023. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review. In International journal of molecular sciences, 24, . doi:10.3390/ijms24043730. https://pubmed.ncbi.nlm.nih.gov/36835142/
2. Kediha, Mohamed Islam, Tazir, Meriem, Sternberg, Damien, Eymard, Bruno, Alipacha, Lamia. 2022. Moderate phenotype of a congenital myasthenic syndrome type 19 caused by mutation of the COL13A1 gene: a case report. In Journal of medical case reports, 16, 134. doi:10.1186/s13256-022-03268-z. https://pubmed.ncbi.nlm.nih.gov/35337379/
3. Nakakura, Takashi, Horiguchi, Kotaro, Suzuki, Takeshi. 2024. Collagen XIII Is the Key Molecule of Neurovascular Junctions in the Neuroendocrine System. In Neuroendocrinology, 114, 658-669. doi:10.1159/000538976. https://pubmed.ncbi.nlm.nih.gov/38643753/
4. Kemppainen, A V, Finnilä, M A, Heikkinen, A, Pihlajaniemi, T, Koivunen, J. 2022. The CMS19 disease model specifies a pivotal role for collagen XIII in bone homeostasis. In Scientific reports, 12, 5866. doi:10.1038/s41598-022-09653-4. https://pubmed.ncbi.nlm.nih.gov/35393492/
5. Marquardt, Robert J, Li, Yuebing. 2019. Congenital myasthenic syndrome type 19 due to a novel mutation in the COL13A1 GENE. In Muscle & nerve, 60, E3-E4. doi:10.1002/mus.26494. https://pubmed.ncbi.nlm.nih.gov/31018245/